Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001557142-17-000128
Filing Date
2017-11-09
Accepted
2017-11-09 16:14:00
Documents
80
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kdmn-20170930x10q.htm 10-Q 2011768
2 EX-31.1 kdmn-20170930xex31_1.htm EX-31.1 19882
3 EX-31.2 kdmn-20170930xex31_2.htm EX-31.2 19903
4 EX-32.1 kdmn-20170930xex32_1.htm EX-32.1 10236
5 EX-32.2 kdmn-20170930xex32_2.htm EX-32.2 10092
  Complete submission text file 0001557142-17-000128.txt   7765677

Data Files

Seq Description Document Type Size
6 EX-101.INS kdmn-20170930.xml EX-101.INS 1402849
7 EX-101.SCH kdmn-20170930.xsd EX-101.SCH 60387
8 EX-101.CAL kdmn-20170930_cal.xml EX-101.CAL 67011
9 EX-101.DEF kdmn-20170930_def.xml EX-101.DEF 269939
10 EX-101.LAB kdmn-20170930_lab.xml EX-101.LAB 455499
11 EX-101.PRE kdmn-20170930_pre.xml EX-101.PRE 473786
Mailing Address 450 EAST 29TH STREET NEW YORK NY 10016
Business Address 450 EAST 29TH STREET NEW YORK NY 10016 212-308-6000
Kadmon Holdings, Inc. (Filer) CIK: 0001557142 (see all company filings)

EIN.: 273576929 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37841 | Film No.: 171190986
SIC: 2834 Pharmaceutical Preparations